| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | PROfound: Phase III study of olaparib versus enzalutamide or abiraterone for metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Sandhu S.K, Hussain M., Mateo J., Fizazi K., Saad F., Shore N., Chi K., Sartor O., Agarwal N., Olmos D., Thiery-Vuillemin A., Twardowski P., Mehra N., Goessl C., Kang J., Burgents J., Wu W., Kohlmann A., Adelman C., de Bono J. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 30 |
| Date Published | NOV |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
